ANG Life Sciences India H1FY22 consolidated PAT zooms to Rs. 33.77 crore

ANG Life Sciences India H1FY22 consolidated PAT zooms to Rs. 33.77 crore

By: IPP Bureau

Last updated : October 26, 2021 11:58 am



ANG Lifesciences India Limited has reported financial results for the period ended September 30, 2021


Financial Results (H1 FY21-22)

The company has reported net sales of Rs.215.5458 crore during the 6 months period ended September 30, 2021 as compared to Rs.68.3789 crore during the period ended March 31, 2021.

The company has posted net profit of Rs.33.7779 crore for the 6 months period ended September 30, 2021 as against Rs.1.5254 crore for the 6 months period ended March 31, 2021.

Financial Results (H1 FY21-22) - YoY Comparison

The company has reported net sales of Rs.215.5458 crore during the 6 months period ended September 30, 2021 as compared to Rs.86.5559 crores during the 6 months period ended September 30, 2020.

The company has posted net profit of Rs.33.7779 crores for the 6 months period ended September 30, 2021 as against Rs.5.5021 crores for the 6 months period ended September 30, 2020.

ANG Lifesciences

First Published : October 26, 2021 12:00 am